US45781K2042 - ADR
2.58 +0.28 (+12.17%)
After market: 2.44 -0.14 (-5.43%)
Overall IPHA gets a technical rating of 2 out of 10. IPHA has been an average performer in the overall market. Also recent evolutions are not that positive: both the medium and short term time frames give negative signs.
IPHA has a bad technical rating, but it does show a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 2.58. Right above this resistance zone may be a good entry point.
When analyzing the support we can see 3 important areas.
2 important resistance areas can be observed.
INNATE PHARMA SA-SPONS ADR
NASDAQ:IPHA (12/8/2023, 7:00:02 PM)After market: 2.44 -0.14 (-5.43%)